Paper Diagnostics Market: About the Report
The global paper diagnostics market is forecast to grow at a steady pace as demand for rapid testing and accurate diagnosis rises in response to increasing cases of cancer and auto-immune diseases, worldwide. While the market was considerably affected due to the outbreak of COVID-19 during the first half of 2020, rising demand from key end-use industries such as hospitals and clinics, home care settings, and others is expected to aid in the fast recovery in the near future. Fact.MR offers a detailed analysis of the market, studying its growth trajectory across North America, Europe, South Asia, East Asia, and other regions.
Paper Diagnostics Market Overview
Increasing awareness regarding the early detection of various auto-immune diseases such as Graves ’ disease, pernicious anemia, Addison disease, and others has been a key growth driver of the paper diagnostics market. According to the World Health Organization (WHO), in 2008, 7.6 million people died from cancer accounting for 13% of all deaths worldwide. And the number of global cancer deaths is projected to increase by 45% through 2030. The rising incidence of cancer is expected to fuel the demand for paper diagnostics.
Steady growth of the hospitals, clinics, home care settings, and other healthcare segments is projected to create growth opportunities for the market between 2020 and 2030. According to the European Commission (EC), in 2018 the total expenditure of general governments on ‘health’ amounted to EUR 944 billion or 7.0% of GDP.
Government stimulus to the healthcare sector is projected to surge in the coming years, fuelling demand for advanced diagnostic technologies. Against this backdrop, despite suffering set-backs due to the ongoing pandemic, the paper diagnostics market is likely to recover gradually over the next year.
Increasing Cases of Autoimmune Diseases Bolstering Growth
Rising cases of autoimmune diseases and cancers coupled with the growing awareness among solutions available for fast and prompt diagnosis have resulted in high demand for the early detection of these diseases.
According to the recent report of National Institutes of Health (NIH) published in April, 2020, the prevalence of autoimmune diseases in the United States was 11.0% for 1988-1991 and it had been increasing steadily to reach at 11.5% during 199-2004 and at 15.9% during 2011-2012.
Paper diagnostics provide promising solutions for early diagnosis of these diseases while emphasizing on the key aspects of the diagnosis procedure and outcomes such as affordability, sustainability, portability, disposability, and others.
According to the National Health and Nutrition Examination Survey (NHANES) of NIH, the rate of auto-immune diseases is forecast to grow further in the United States in the coming years. The data indicates that demand for paper diagnostics will surge considerably in the coming years
Regional Outlook of Paper Diagnostics Market
North America is the leading market for paper diagnostics in the world owing to the rising cases of cancer and advanced healthcare infrastructure. According to the National Cancer Institute, the U.S. is likely to have 1,806,590 new cases of cancer in 2020 and nearly 606,520 people might succumb to the disease. The demand for early and effective detection of cancer has therefore become a priority for the healthcare industry in North America. This in turn is boosting the demand for paper diagnostics in the region.
Europe is the second-leading market for paper diagnostics and is set to sustain its position through the forecast period. The presence of well-developed healthcare sector, coupled with the support from government are propelling the growth in Europe. For instance, a new policy adopted by the European Health Commission includes four pillars to beat cancers which are- prevention, early diagnosis, treatment, and follow-up care.
The presence of favorable policies such as this is creating environment conducive to the growth of the market. Fact MR has identified countries such as Germany, France, Italy, and others as highly lucrative pockets for paper diagnostics sales within Europe.
Asia Pacific is the fastest growing region in the global market and is expected to remain in the position due to the steady rise in demand for early and reliable detection of the diseases such as diabetes, cancer, tuberculosis, and others.
According to the World Health Organization (WHO), more than half worldwide cases of tuberculosis are reported in South-East Asia and Western Pacific region. This has significantly contributed to the surge in demand for paper diagnostics in East Asia.
For deeper knowledge surrounding the growth prospects of regional markets for paper diagnostics, ask an expert analyst
Paper Diagnostics Market Insights by Product
Presently, lateral flow assays are the leading segment in terms of product type in the global paper diagnostics market. Lateral flow assays paper diagnostics are widely popular in the healthcare segments such as hospitals, clinics, home care settings, and others because they offer more sophisticated, cost-effective, and reliable diagnostics solutions for the early diagnosis of various autoimmune diseases and cancers.
Paper Diagnostics Market Insights by End User
Presently hospitals and clinics segment is the leading end user in the paper diagnostics market and is set to maintain the lead through the forecast period. With the increase in awareness among doctors, other healthcare staff, and patients, the demand for paper diagnostics solutions is rising.
The European Centre for Disease Prevention and Control (ECDC) has recently launched their online program for Continuous Professional Development along with the advanced tools and documents aiming for advancement in the healthcare industry. The initiatives like this are intended to increase awareness among healthcare professionals about various healthcare solutions. Such initiatives are creating prospects for growth within the hospitals and clinics segment.
Home care settings has emerged another lucrative end user and is expected to continue exhibiting increasing demand for paper diagnostics over the forecast period. According to the National Center for Bio Technology Information (NCBI), 8090 home health care agencies in the United States provide care for more than 2.4 million elderly and disabled people annually. An increasing number of patients and their families are likely to adopt advanced home care solutions in the near future. This will in turn fuel demand for paper diagnostics in the coming years.
Paper Diagnostics Market: Competitive Landscape
Companies operating in the paper diagnostics market are focusing on product launches as one of their key strategies to gain competitive advantage.
- For instance, Siemens Healthineers launched its new range of paper diagnostics solutions such as FTD Respiratory Assays using multiplex RT-PCR, VERSANT HCV Genotype 2.0 Assay (LiPA), and others in the current year.
- Arkray Inc. launched its new extensive range of paper diagnostics solutions such as HbA1c Analyzer, Orinalyser U500, and others in the recent year.
Key companies operating in the paper diagnostics market are-
- Acon Laboratories
- Bio-Rad Laboratories Inc.
- Siemens Healthineers
- Chembio Diagnostic Systems Inc.
- Arkray Inc.
- Cytodiagnostics Inc.
The Analyst’s Viewpoint
“For instance, according to the National Institutes of Health (NIH), the prevalence of autoimmune diseases in Italy is highest for autoimmune thyroiditis (2,619 per 100,000) followed by psoriatic arthritis (939 per 100,000), type 1 diabetes (464 per 100,000), and others. With the incidence of diabetes and autoimmune diseases unlikely to reduce in the coming years, market players are expected the demand for paper diagnostics to pick up in the coming years.”
COVID-19 Impact on Paper Diagnostics Market
The outbreak of the COVID-19 pandemic caused temporary decline in the growth of the paper diagnostics market, especially since the focus of the healthcare industry shifted towards dealing with emergency caused due to the virus outbreak.
However, demand is expected to pick up since the demand for effective solutions for rapid testing of infectious diseases is at all-time high. Awareness is improving across countries such as Chile, Brazil, Mexico, and others, which will favor the overall expansion of the market in the coming years.
Paper Diagnostics Market - Scope of the Report
A recent study by Fact.MR on the paper diagnostics market offers a 10-year forecast from 2020 to 2030. The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with the manufacturing of paper diagnostics. The study also provides the dynamics that are responsible for influencing the future status of the paper diagnostics market over the forecast period.
A detailed assessment of the paper diagnostics value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the paper diagnostics market, along with their product portfolios, enhances the reliability of this comprehensive research study.
Paper Diagnostics Market: Report Summary
The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the paper diagnostics market across the globe.
A comprehensive estimate on the paper diagnostics market has been provided through an optimistic as well as a conservative scenario, taking into account sales during the forecast period. Price point comparison by region with global average price is also considered in the study.
Paper Diagnostics Market – Segmentation
Fact.MR’s research study assesses the global paper diagnostics market in terms of product type, end user, and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the global paper diagnostics market.
Key Questions Answered in Fact.MR’s Paper Diagnostics Market Report
- Which are the most lucrative markets for paper diagnostics?
- Which factors will impact paper diagnostics market growth?
- How will changing trends impact the strategy of market players?
- How can market players capture the low-hanging opportunities?
- Which companies are leading the paper diagnostics market?
- What are the winning strategies of stakeholders in the paper diagnostics market?
Paper Diagnostics Market: Inspected Assessment on Regional Segments
Key sections have been elaborated in the paper diagnostics market report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the paper diagnostics market during the forecast period.
Country-specific valuation on demand for paper diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.
Detailed breakup in terms of value for emerging countries has also been included in the report.
Paper Diagnostics Market: Research Methodology
In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the paper diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.
Secondary resources referred to by analysts during the preparation of the paper diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the paper diagnostics market report as a primary resource.
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Paper Diagnostics Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Key Product Features and their USPs
4.2. Product Adoption / Usage Analysis
4.3. Disease Epidemiology
4.4. Key Promotional Strategies, By Manufacturers
4.5. Regulations, By Region
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Rise in Healthcare Expenditure
5.1.2. Increasing R&D Expenditure
5.1.3. Income Per Capita Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Rising Prevalence of Diseases such as Cancer and Autoimmune Diseases
5.2.2. Increasing Demand for Novel and Rapid Diagnostics Techniques
5.2.3. Growing Levels of Pollution in Environments Resulting in Greater Concerns Regarding Detection of Pollutants
5.2.4. Increasing Adaption of the Point of Care Diabetes and Pregnancy Test Kits
5.3. Market Dynamics
5.3.3. Opportunity Analysis
5.4. Market Entry Strategy
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue by Product
6.4.2. Revenue by End User
6.4.3. Revenue by Country
6.5. 2020 Market Scenario
6.6. Quarter by Quarter Forecast
6.7. Projected recovery Quarter
6.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Paper Diagnostics Market - Pricing Analysis
7.1. Country Pricing Analysis by Product
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Latin America and Middle East Average Pricing Analysis Benchmark
8. Global Paper Diagnostics Market Value Analysis 2015 – 2019 and Forecast, 2020 – 2030
8.1. Historical Market Value (US$ Mn) Analysis, 2015 – 2019
8.2. Current and Future Market Value (US$ Mn) Projections, 2020 – 2030
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Global Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Product, 2015 – 2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, 2020 – 2030
9.3.1. Lateral Flow Assays
9.3.3. Paper Based Microfluidics
9.4. Market Attractiveness Analysis by Product
10. Global Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by End User, 2015 – 2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2020 – 2030
10.3.1. Hospitals & Clinics
10.3.2. Homecare Settings
10.4. Market Attractiveness Analysis, by End User
11. Global Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030, by Region
11.2. Historical Market Size (US$ Mn) Analysis by Region, 2015 – 2019
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
11.3.1. North America
11.3.2. Latin America
11.3.4. East Asia
11.3.5. South Asia
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis by Region
11.5. SWOT Analysis by Region
12. North America Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
13. Latin America Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
13.3.1. By Country
188.8.131.52. Rest of Latin America
13.3.2. By Product
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Europe Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
14.3.1. By Country
184.108.40.206. Rest of Europe
14.3.2. By Product
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. South Asia Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
15.3.1. By Country
220.127.116.11. Rest of South Asia
15.3.2. By Product
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. East Asia Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
16.3.1. By Country
18.104.22.168. South Korea
22.214.171.124. Rest of East Asia
16.3.2. By Product
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. Oceania Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 – 2019
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2020 - 2030
17.3.1. By Country
126.96.36.199. New Zealand
17.3.2. By Product
17.3.3. By End User
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 – 2019
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030
18.3.1. By Country
188.8.131.52. GCC Countries
184.108.40.206. South Africa
220.127.116.11. Rest of Middle East and Africa
18.3.2. By Product
18.3.3. By End User
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Paper Diagnostics Market Analysis 2015 – 2019 and Forecast 2020 – 2030
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Paper Diagnostics Market Analysis
19.2.1. By Product
19.2.2. By End User
19.3. Canada Paper Diagnostics Market Analysis
19.3.1. By Product
19.3.2. By End User
19.4. Mexico Paper Diagnostics Market Analysis
19.4.1. By Product
19.4.2. By End User
19.5. Brazil Paper Diagnostics Market Analysis
19.5.1. By Product
19.5.2. By End User
19.6. U.K. Paper Diagnostics Market Analysis
19.6.1. By Product
19.6.2. By End User
19.7. Germany Paper Diagnostics Market Analysis
19.7.1. By Product
19.7.2. By End User
19.8. France Paper Diagnostics Market Analysis
19.8.1. By Product
19.8.2. By End User
19.9. Italy Paper Diagnostics Market Analysis
19.9.1. By Product
19.9.2. By End User
19.10. Spain Paper Diagnostics Market Analysis
19.10.1. By Product
19.10.2. By End User
19.11. BENELUX Paper Diagnostics Market Analysis
19.11.1. By Product
19.11.2. By End User
19.12. Russia Paper Diagnostics Market Analysis
19.12.1. By Product
19.12.2. By End User
19.13. China Paper Diagnostics Market Analysis
19.13.1. By Product
19.13.2. By End User
19.14. Japan Paper Diagnostics Market Analysis
19.14.1. By Product
19.14.2. By End User
19.15. South Korea Paper Diagnostics Market Analysis
19.15.1. By Product
19.15.2. By End User
19.16. India Paper Diagnostics Market Analysis
19.16.1. By Product
19.16.2. By End User
19.17. ASEAN Paper Diagnostics Market Analysis
19.17.1. By Product
19.17.2. By End User
19.18. Australia Paper Diagnostics Market Analysis
19.18.1. By Product
19.18.2. By End User
19.19. New Zealand Paper Diagnostics Market Analysis
19.19.1. By Product
19.19.2. By End User
19.20. GCC Countries Paper Diagnostics Market Analysis
19.20.1. By Product
19.20.2. By End User
19.21. Turkey Paper Diagnostics Market Analysis
19.21.1. By Product
19.21.2. By End User
19.22. South Africa Paper Diagnostics Market Analysis
19.22.1. By Product
19.22.2. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional Foot Print of Players
20.4.2. Product Foot Print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Pricing Analysis by Competition
21.3. Competition Benchmarking
21.4. Competition Deep Dive
21.4.1. Abcam PLC
18.104.22.168. Product Portfolio
22.214.171.124. Profitability by Market Segments (Brand/Distribution Channel/Region)
126.96.36.199. Sales Footprint
188.8.131.52. Strategy Overview
184.108.40.206.1. Marketing Strategy
220.127.116.11.2. Product Strategy
18.104.22.168.3. Channel Strategy
21.4.2. Acon Laboratories
22.214.171.124. Product Portfolio
126.96.36.199. Profitability by Market Segments (Brand/Distribution Channel/Region)
188.8.131.52. Sales Footprint
184.108.40.206. Strategy Overview
220.127.116.11.1. Marketing Strategy
18.104.22.168.2. Product Strategy
22.214.171.124.3. Channel Strategy
21.4.3. Bio-Rad Laboratories Inc.
126.96.36.199. Product Portfolio
188.8.131.52. Profitability by Market Segments (Brand/Distribution Channel/Region)
184.108.40.206. Sales Footprint
220.127.116.11. Strategy Overview
18.104.22.168.1. Marketing Strategy
22.214.171.124.2. Product Strategy
126.96.36.199.3. Channel Strategy
21.4.4. Siemens Healthineers
188.8.131.52. Product Portfolio
184.108.40.206. Profitability by Market Segments (Brand/Distribution Channel/Region)
220.127.116.11. Sales Footprint
18.104.22.168. Strategy Overview
22.214.171.124.1. Marketing Strategy
126.96.36.199.2. Product Strategy
188.8.131.52.3. Channel Strategy
21.4.5. Chembio Diagnostic Systems Inc.
184.108.40.206. Product Portfolio
220.127.116.11. Profitability by Market Segments (Brand/Distribution Channel/Region)
18.104.22.168. Sales Footprint
22.214.171.124. Strategy Overview
126.96.36.199.1. Marketing Strategy
188.8.131.52.2. Product Strategy
184.108.40.206.3. Channel Strategy
21.4.6. Arkray Inc.
220.127.116.11. Product Portfolio
18.104.22.168. Profitability by Market Segments (Brand/Distribution Channel/Region)
22.214.171.124. Sales Footprint
126.96.36.199. Strategy Overview
188.8.131.52.1. Marketing Strategy
184.108.40.206.2. Product Strategy
220.127.116.11.3. Channel Strategy
21.4.7. Cytodiagnostics Inc.
18.104.22.168. Product Portfolio
22.214.171.124. Profitability by Market Segments (Brand/Distribution Channel/Region)
126.96.36.199. Sales Footprint
188.8.131.52. Strategy Overview
184.108.40.206.1. Marketing Strategy
220.127.116.11.2. Product Strategy
18.104.22.168.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.